Le rekkie del gold

[corto]

giretto prima di cena tanto per fare fame TDC

 

[corto]

Monte Pelmo e Monte CIVETTA

 

[corto]

primi battibecchi nella coppia?

summa silver inizia a fare volumetti

Vedi l'allegato 603878

 

[ilpensionato]

Vedi l'allegato 605705Vedi l'allegato 605703





giretto prima di cena tanto per fare fame TDC

Se non lavori fame non ti viene

 

[corto]

Se non lavori fame non ti viene

cazzo dici
faccio analisi gratis per voi terroni
vi do delle chicche in regalo
e dici che non lavoro?
fatti inkulare dal tuo amore torinese

 

[ilpensionato]

cazzo dici
faccio analisi gratis per voi terroni
vi do delle chicche in regalo
e dici che non lavoro?
fatti inkulare dal tuo amore torinese

Non ho amici ma solo nemici...pdm

 

[ilpensionato]

GOLD
dopo i 1900 in arrivo, "necesse est" il superamento del 1960.........da li dritti al test ultimo max

ho portato un emendamento al prossimo ddl zan........la parola terrone verra messa tra gli insulti...........la parola frociorom invece sara di prossima coniatura all'accademia dei lincei

1910
PDM
TDC
altro...

 

[legolego]

per chi era dentro
NBRV + 40%

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacinLefamulin was generally safe and...

finance.yahoo.com

 

[bacucco]

per chi era dentro
NBRV + 40%

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacinLefamulin was generally safe and...

finance.yahoo.com

per chi era dentro
NBRV + 40%

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacinLefamulin was generally safe and...

finance.yahoo.com

Ho recuperato parte del loss

 

[corto]